Spotlight on UK | Investor Action on AMR Sponsored by: Moderator: Louise Norton-Smith – Head of Global Antimicrobial Resistance Strategy & Delivery, UK…
Regulatory perspective | Current status and the post-COVID outlook for antibiotic clinical trials & approvals Moderator: John Rex, Chief Medical Officer, F2G Ltd. Speakers:…
Global markets | Why we need to think global to tackle AMR Moderator: Marc Lemonnier – Founding CEO, Antabio SAS Speakers: Heiman Wertheim –…
Diagnostics | Novel solutions to solve the reimbursement challenge Moderator: Till Bachmann – Deputy Head of Infection Medicine and Personal chair of Molecular Diagnostics…
AMR pull incentives | Will COVID-19 speed up or slow down implementation? Moderator: Kathy Talkington, Director Health Programs, Pew Charitable Trust Speakers: Suzanne Edwards…
Business models in AMR | How to develop strategic decisions in a challenging and global AMR market Sponsored by: Moderator: Gökhan Batur – CEO,…
Business models | The AMR company of the future – Which route to success Sponsored by: Moderator: Erin Duffy – Chief of Research &…
